<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="1" ids="7459">Naloxone</z:chebi> has been advanced as a potential neuroprotectant against ischemic injury </plain></SENT>
<SENT sid="1" pm="."><plain>This study examined the involvement of classical opioid receptors in the reduction of middle cerebral arterial ligation-induced cortical infarction in rats </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:mpath ids='MPATH_124'>infarct</z:mpath> volume was significantly reduced after infusion of (-)-<z:chebi fb="1" ids="7459">naloxone</z:chebi>, but not its inert stereoisomer (+)-<z:chebi fb="1" ids="7459">naloxone</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Beta-funaltrexamine (beta-FNA), a mu opioid <z:chebi fb="68" ids="48706">antagonist</z:chebi>, also reduced ischemic <z:mpath ids='MPATH_124'>infarct</z:mpath> volume </plain></SENT>
<SENT sid="4" pm="."><plain>Both (-)-<z:chebi fb="1" ids="7459">naloxone</z:chebi> and beta-FNA attenuated <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>/reperfusion (I/R)-induced increases in neutrophil-associated myeloperoxidase activity and chemokine <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression, including macrophage inflammatory protein-1 alpha and -2 </plain></SENT>
<SENT sid="5" pm="."><plain>However, (-)-<z:chebi fb="1" ids="7459">naloxone</z:chebi> and beta-FNA failed to decrease cerebral I/R-induced <z:hpo ids='HP_0002181'>brain edema</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The findings suggest that <z:chebi fb="1" ids="7459">naloxone</z:chebi>, acting through a blockade of mu opioid receptor activation, is beneficial to cerebral I/R insult in terms of reducing <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e>, neutrophil accumulation, and chemokine expression </plain></SENT>
</text></document>